cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.15468/dl.dujs2q
title: Occurrence Download

description: A dataset containing 130341 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is Buteo rufinus",
 "HasCoordinate is true",
 "HasGeospatialIssue is false",
 "Geometry POLYGON((-180 -90, 180 -90, 180 90, -180 90, -180 -90))"
 ]
}

 The dataset includes 130341 records from 171 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0063659-251120083545085/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.d3j99u
title: Occurrence Download

description: A dataset containing 229722 species occurrences available in GBIF matching the query:
{
 "and" : [
 "Continent is Asia",
 "Country is one of (China, Chinese Taipei)",
 "OccurrenceStatus is Present",
 "TaxonKey is Chordata",
 "Year 2025-2025"
 ]
}

 The dataset includes 229722 records from 32 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0063669-251120083545085/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.21227/75bv-c744
title: "Videos presented to subject: dynamics presentation interface"

description: "This video is intended to assist the operator in switching the internal model when operating a teleoperated hydraulic excavator. By visually presenting the motion of the machine to be operated next at the time of machine switching, the operator is encouraged to switch to the appropriate internal model, and efficient operation is enabled."
DOI: 10.5281/zenodo.18029105
title: Data for: "Deciphering the guest-free crystal structures and thermal breathing of the flexible metal-organic frameworks ZIF-7 and ZIF-9"

description: Three-dimensional electron diffraction data collected for the publication "Deciphering the guest-free crystal structures and thermal breathing of the flexible metal-organic frameworks ZIF-7 and ZIF-9".

The following files are contained within this entry:



ZIF-7_cryo_40x.avi - Sped up video (×40) showing all of the collected diffraction frames of one of four crystals of ZIF-7.

ZIF-7_data.zip - Zipped folder containing all of the data in REDp and XDS format.

ZIF-9_cryo_40x.avi - Sped up video (×40) showing all of the collected diffraction frames of one of four crystals of ZIF-9.

ZIF-9_data.zip - Zipped folder containing all of the data in REDp and XDS format.


The zipped data folders contain all four individual datasets, as well as a folder with the integrated merged data (cluster_1) that contains the merged data in SHELX format and the raw structure solutions from SHELXT (subfolders solve_merged/shelxt).
DOI: 10.5281/zenodo.18029106
title: Data for: "Deciphering the guest-free crystal structures and thermal breathing of the flexible metal-organic frameworks ZIF-7 and ZIF-9"

description: Three-dimensional electron diffraction data collected for the publication "Deciphering the guest-free crystal structures and thermal breathing of the flexible metal-organic frameworks ZIF-7 and ZIF-9".

The following files are contained within this entry:



ZIF-7_cryo_40x.avi - Sped up video (×40) showing all of the collected diffraction frames of one of four crystals of ZIF-7.

ZIF-7_data.zip - Zipped folder containing all of the data in REDp and XDS format.

ZIF-9_cryo_40x.avi - Sped up video (×40) showing all of the collected diffraction frames of one of four crystals of ZIF-9.

ZIF-9_data.zip - Zipped folder containing all of the data in REDp and XDS format.


The zipped data folders contain all four individual datasets, as well as a folder with the integrated merged data (cluster_1) that contains the merged data in SHELX format and the raw structure solutions from SHELXT (subfolders solve_merged/shelxt).
DOI: 10.6084/m9.figshare.30938777
title: Supplementary Material for: A Network Meta-Analysis of Pharmacological Treatments for Gastric Mucosal Protection in Artificial Ulcers Following Endoscopic Submucosal Dissection (ESD) of the Stomach

description: Background: Proton pump inhibitor (PPI) monotherapy is standard for artificial ulcer healing after gastric endoscopic submucosal dissection (ESD), but evidence on the efficacy of PPI combined with gastric mucosal protectants remains inconclusive.
Aim: To compare the efficacy of 10 mucosal protectants combined with PPIs through a network meta-analysis (NMA).
Methods: We systematically searched PubMed, Embase, Cochrane Library, Web of Science, and ClinicalTrials.gov until January 2025. Included were 20 randomized controlled trials (RCTs, n=2000) comparing PPI monotherapy versus PPI combined with protectants (e.g., rebamipide, ecabet, polaprezinc) or active controls. Primary outcomes included ulcer area reduction, healing rates (4/8 weeks), longest ulcer diameter, and bleeding risk. Frequentist random-effects models synthesized risk ratios and mean differences with 95% CIs. Consistency was evaluated using design-by-treatment interaction and node splitting. Risk of bias (RoB 2.0) was assessed at the outcome level. Certainty of evidence was graded with GRADE.
Results: Bismuth subcitrate-magnesium granules (BMG) + PPI most effectively reduced 4-week ulcer area (mean difference [MD]: -62.50 mm², 95% CI: -87.25 to -37.75 vs. PPI; SUCRA=94%). Ecabet sodium (EB) + PPI achieved the highest 8-week healing rate (risk ratio [RR]: 7.71, 95% CI: 5.52--9.91). Hydrotalcite (HT) + PPI best reduced ulcer diameter (MD: -1.87 mm), while teprenone (TN) + PPI optimally prevented bleeding (RR: -3.41, 95% CI: -5.43 to -1.38). Rebamipide + PPI showed efficacy heterogeneity, particularly in large ulcers (&gt;40 mm).
Conclusions: PPI-based combinations likely accelerate healing versus PPI alone, but conclusions are hypothesis-generating given indirect evidence and regional concentration of trials. Combination therapy outperforms PPI monotherapy. BMG+PPI is optimal for early ulcer healing, EB+PPI for long-term healing, HT+PPI for diameter reduction, and TN+PPI for bleeding prevention. Stratified regimens by ulcer characteristics are recommended.
DOI: 10.6084/m9.figshare.30938777.v1
title: Supplementary Material for: A Network Meta-Analysis of Pharmacological Treatments for Gastric Mucosal Protection in Artificial Ulcers Following Endoscopic Submucosal Dissection (ESD) of the Stomach

description: Background: Proton pump inhibitor (PPI) monotherapy is standard for artificial ulcer healing after gastric endoscopic submucosal dissection (ESD), but evidence on the efficacy of PPI combined with gastric mucosal protectants remains inconclusive.
Aim: To compare the efficacy of 10 mucosal protectants combined with PPIs through a network meta-analysis (NMA).
Methods: We systematically searched PubMed, Embase, Cochrane Library, Web of Science, and ClinicalTrials.gov until January 2025. Included were 20 randomized controlled trials (RCTs, n=2000) comparing PPI monotherapy versus PPI combined with protectants (e.g., rebamipide, ecabet, polaprezinc) or active controls. Primary outcomes included ulcer area reduction, healing rates (4/8 weeks), longest ulcer diameter, and bleeding risk. Frequentist random-effects models synthesized risk ratios and mean differences with 95% CIs. Consistency was evaluated using design-by-treatment interaction and node splitting. Risk of bias (RoB 2.0) was assessed at the outcome level. Certainty of evidence was graded with GRADE.
Results: Bismuth subcitrate-magnesium granules (BMG) + PPI most effectively reduced 4-week ulcer area (mean difference [MD]: -62.50 mm², 95% CI: -87.25 to -37.75 vs. PPI; SUCRA=94%). Ecabet sodium (EB) + PPI achieved the highest 8-week healing rate (risk ratio [RR]: 7.71, 95% CI: 5.52--9.91). Hydrotalcite (HT) + PPI best reduced ulcer diameter (MD: -1.87 mm), while teprenone (TN) + PPI optimally prevented bleeding (RR: -3.41, 95% CI: -5.43 to -1.38). Rebamipide + PPI showed efficacy heterogeneity, particularly in large ulcers (&gt;40 mm).
Conclusions: PPI-based combinations likely accelerate healing versus PPI alone, but conclusions are hypothesis-generating given indirect evidence and regional concentration of trials. Combination therapy outperforms PPI monotherapy. BMG+PPI is optimal for early ulcer healing, EB+PPI for long-term healing, HT+PPI for diameter reduction, and TN+PPI for bleeding prevention. Stratified regimens by ulcer characteristics are recommended.
DOI: 10.6084/m9.figshare.30938780
title: Supplementary Material for: Dairy product intake alters the correlations between circulating bile acids and short-chain fatty acids with the bacterial taxa Roseburia, Faecalibacterium, Flavonifractor and Verrucomicrobia

description: Introduction: Type 2 diabetes (T2D) risk factors are associated with gut microbiota dysregulation that can alter circulating metabolites levels such as bile acids (BAs) and short-chain fatty acids (SCFAs). The objective is to investigate how the high dairy intake (HD) (≥ 4 servings/day) product intake compared to adequate dairy (AD) (≤ 2 servings/day) intake influences the correlations between Roseburia, Faecalibacterium, Flavonifractor as well as Verrucomicrobia and circulating BAs and SCFAs in subjects at risk of T2D. Methods: In a randomized crossover trial, 10 hyperinsulinemic adults were randomized to HD or AD for 6 weeks separated by a 6-week washout period. Gut microbiota were measured with 16S rRNA-based high-throughput sequencing in the gut. BA profiling in plasma was performed by high-performance liquid chromatography-tandem mass spectrometry. Serum SCFAs were determined using headspace gas-chromatography. Results: No significant differences were observed in mean circulating BA or SCFA levels between AD and HD consumption. Verrucomicrobia and Flavonifractor showed positive correlations with secondary BAs, following HD and AD intake, respectively. Additionally, Flavonifractor correlated positively with acetic and propionic acids after HD intake. Roseburia correlated positively with primary BAs, propionate and butyrate after HD intake. Faecalibacterium was positively correlated with cholic acid after AD intake and with hexanoic acid after HD intake. Conclusion: These findings suggest that high dairy intake may modulate microbiota–metabolite interactions without altering circulating metabolite concentrations, highlighting a potential role for dietary patterns in shaping gut-derived metabolic signals in individuals at risk of T2D.
DOI: 10.6084/m9.figshare.30938780.v1
title: Supplementary Material for: Dairy product intake alters the correlations between circulating bile acids and short-chain fatty acids with the bacterial taxa Roseburia, Faecalibacterium, Flavonifractor and Verrucomicrobia

description: Introduction: Type 2 diabetes (T2D) risk factors are associated with gut microbiota dysregulation that can alter circulating metabolites levels such as bile acids (BAs) and short-chain fatty acids (SCFAs). The objective is to investigate how the high dairy intake (HD) (≥ 4 servings/day) product intake compared to adequate dairy (AD) (≤ 2 servings/day) intake influences the correlations between Roseburia, Faecalibacterium, Flavonifractor as well as Verrucomicrobia and circulating BAs and SCFAs in subjects at risk of T2D. Methods: In a randomized crossover trial, 10 hyperinsulinemic adults were randomized to HD or AD for 6 weeks separated by a 6-week washout period. Gut microbiota were measured with 16S rRNA-based high-throughput sequencing in the gut. BA profiling in plasma was performed by high-performance liquid chromatography-tandem mass spectrometry. Serum SCFAs were determined using headspace gas-chromatography. Results: No significant differences were observed in mean circulating BA or SCFA levels between AD and HD consumption. Verrucomicrobia and Flavonifractor showed positive correlations with secondary BAs, following HD and AD intake, respectively. Additionally, Flavonifractor correlated positively with acetic and propionic acids after HD intake. Roseburia correlated positively with primary BAs, propionate and butyrate after HD intake. Faecalibacterium was positively correlated with cholic acid after AD intake and with hexanoic acid after HD intake. Conclusion: These findings suggest that high dairy intake may modulate microbiota–metabolite interactions without altering circulating metabolite concentrations, highlighting a potential role for dietary patterns in shaping gut-derived metabolic signals in individuals at risk of T2D.
DOI: 10.6084/m9.figshare.30938783
title: Supplementary Material for: Response rate correlates with the conversion rate in patients with advanced hepatocellular carcinoma treated with systemic or hepatic artery infusion chemotherapy: a systematic review

description: Background: The appropriate regimen for induction therapy with the intent of conversion therapy for advanced hepatocellular carcinoma (HCC) is unknown. This study aimed to evaluate whether the overall response rate (ORR) of chemotherapy correlates with the conversion rate.
Summary: The studies of phase 2/3 trials of systemic or hepatic arterial infusion chemotherapy (HAIC) for patients with advanced HCC were searched. A total of 42 patient groups from 32 trials were included in the analysis. The ORR and conversion rates in a total of 3516 patients were 24.7% and 8.3%, respectively. The analysis of only the patient groups treated with 1st-line immune checkpoint inhibitors, tyrosine-kinase inhibitors or HAIC revealed strong correlation between the ORR and the conversion rate (ρ=0.647, p=0.0003). In addition, strong correlations between the ORR and median PFS/OS were observed (ρ=0.772, p&lt;0.0001 and ρ=0.754, p&lt;0.0001, respectively). 
Messages: Because of the strong correlations of the ORR with the conversion rate and PFS/OS, regimens with high ORRs may be used for patients with advanced HCC who are potential candidates for conversion therapy.
DOI: 10.6084/m9.figshare.30938783.v1
title: Supplementary Material for: Response rate correlates with the conversion rate in patients with advanced hepatocellular carcinoma treated with systemic or hepatic artery infusion chemotherapy: a systematic review

description: Background: The appropriate regimen for induction therapy with the intent of conversion therapy for advanced hepatocellular carcinoma (HCC) is unknown. This study aimed to evaluate whether the overall response rate (ORR) of chemotherapy correlates with the conversion rate.
Summary: The studies of phase 2/3 trials of systemic or hepatic arterial infusion chemotherapy (HAIC) for patients with advanced HCC were searched. A total of 42 patient groups from 32 trials were included in the analysis. The ORR and conversion rates in a total of 3516 patients were 24.7% and 8.3%, respectively. The analysis of only the patient groups treated with 1st-line immune checkpoint inhibitors, tyrosine-kinase inhibitors or HAIC revealed strong correlation between the ORR and the conversion rate (ρ=0.647, p=0.0003). In addition, strong correlations between the ORR and median PFS/OS were observed (ρ=0.772, p&lt;0.0001 and ρ=0.754, p&lt;0.0001, respectively). 
Messages: Because of the strong correlations of the ORR with the conversion rate and PFS/OS, regimens with high ORRs may be used for patients with advanced HCC who are potential candidates for conversion therapy.
DOI: 10.6084/m9.figshare.30938786
title: Supplementary Material for: Anterior Chamber Sulfur Hexafluoride (SF6) Injection for Hypotony Management: Case Report and Literature Review

description: Introduction: Hypotony is a potentially vision-threatening condition that may persist despite conservative management, often necessitating surgical or interventional treatment. We present a case where a minimally invasive injection of 100% sulfur hexafluoride (SF6) into the anterior chamber (AC) successfully reversed refractory hypotony secondary to ciliary body shut-down. 
Case Presentation: A 72-year-old male with advanced pseudoexfoliation glaucoma and a nonfunctioning trabeculectomy presented with hypotony, decreased vision, a deep AC, and 360° serous choroidal effusions. After excluding other etiologies, ciliary body shutdown was presumed. Conventional measures, including topical steroids, cycloplegia, and AC viscoelastic injection, failed to restore intraocular pressure (IOP). Given the refractory course, 100% SF6 gas was injected into the AC. Within 24 hours, a reverse pupillary block developed, leading to a rapid IOP increase. The gas fully reabsorbed within weeks, with resolution of the choroidal effusions and normalization of IOP. At six months, the patient maintained stable IOP and visual acuity without further intervention.
Conclusion: This case highlights the potential of SF6 gas injection as a minimally invasive and effective treatment for refractory hypotony, even when the underlying mechanism is not over-filtration.
DOI: 10.6084/m9.figshare.30938786.v1
title: Supplementary Material for: Anterior Chamber Sulfur Hexafluoride (SF6) Injection for Hypotony Management: Case Report and Literature Review

description: Introduction: Hypotony is a potentially vision-threatening condition that may persist despite conservative management, often necessitating surgical or interventional treatment. We present a case where a minimally invasive injection of 100% sulfur hexafluoride (SF6) into the anterior chamber (AC) successfully reversed refractory hypotony secondary to ciliary body shut-down. 
Case Presentation: A 72-year-old male with advanced pseudoexfoliation glaucoma and a nonfunctioning trabeculectomy presented with hypotony, decreased vision, a deep AC, and 360° serous choroidal effusions. After excluding other etiologies, ciliary body shutdown was presumed. Conventional measures, including topical steroids, cycloplegia, and AC viscoelastic injection, failed to restore intraocular pressure (IOP). Given the refractory course, 100% SF6 gas was injected into the AC. Within 24 hours, a reverse pupillary block developed, leading to a rapid IOP increase. The gas fully reabsorbed within weeks, with resolution of the choroidal effusions and normalization of IOP. At six months, the patient maintained stable IOP and visual acuity without further intervention.
Conclusion: This case highlights the potential of SF6 gas injection as a minimally invasive and effective treatment for refractory hypotony, even when the underlying mechanism is not over-filtration.
DOI: 10.6084/m9.figshare.30938789
title: Supplementary Material for: A case series of SGLT2i improving hemoglobin in adults with myelodysplastic syndrome

description: Introduction: The objective of our case series was to assess the change in hemoglobin for adults with myelodysplastic syndrome (MDS) started on a sodium glucose cotransporter 2 inhibitor (SGLT2i) for their diabetes, heart failure, or chronic kidney disease.

Case Presentation: Five consecutive patients with bone marrow biopsy confirmed low or intermediate risk MDS were referred for consideration of SGLT2i between July 2024 and December 2024. The patients were followed prospectively and had a repeat complete blood count at least 3 months after starting empagliflozin at 10 mg daily. Four of the five patients provided written consent for their results to be published. Median age was 78 years (range 76 to 82 years), three of the four patients were men, and the median baseline hemoglobin was 11.6 g/dL (IQR 9.3–12.8). Over a median duration of 4 months of taking empagliflozin, the median repeat hemoglobin was 12.8 g/dL (IQR 10.3–13.7).

Conclusions: In our case series of four patients with MDS started on empagliflozin, we observed an increase in hemoglobin for all four patients. Larger studies are needed to assess whether the increase in hemoglobin is sufficiently robust and sustained to reduce a person’s need for future red blood cell transfusion or other treatments for MDS.
DOI: 10.6084/m9.figshare.30938789.v1
title: Supplementary Material for: A case series of SGLT2i improving hemoglobin in adults with myelodysplastic syndrome

description: Introduction: The objective of our case series was to assess the change in hemoglobin for adults with myelodysplastic syndrome (MDS) started on a sodium glucose cotransporter 2 inhibitor (SGLT2i) for their diabetes, heart failure, or chronic kidney disease.

Case Presentation: Five consecutive patients with bone marrow biopsy confirmed low or intermediate risk MDS were referred for consideration of SGLT2i between July 2024 and December 2024. The patients were followed prospectively and had a repeat complete blood count at least 3 months after starting empagliflozin at 10 mg daily. Four of the five patients provided written consent for their results to be published. Median age was 78 years (range 76 to 82 years), three of the four patients were men, and the median baseline hemoglobin was 11.6 g/dL (IQR 9.3–12.8). Over a median duration of 4 months of taking empagliflozin, the median repeat hemoglobin was 12.8 g/dL (IQR 10.3–13.7).

Conclusions: In our case series of four patients with MDS started on empagliflozin, we observed an increase in hemoglobin for all four patients. Larger studies are needed to assess whether the increase in hemoglobin is sufficiently robust and sustained to reduce a person’s need for future red blood cell transfusion or other treatments for MDS.
DOI: 10.34740/kaggle/dsv/14265091
title: Peer-to-Peer Boliviano (BOB) Exchange Data
DOI: 10.25959/xnjr-hv18
title: Hygrothermal Performance in Intermittently Conditioned 7-Star Housing, South-East Australia (Brick Veneer)

description: This study examines the hygrothermal performance of 7-Star rated homes in South-East Australia when operated under intermittent air-conditioning schedules. It investigates how varying cooling and heating patterns influence indoor temperature, relative humidity, and overall comfort conditions throughout different climate zones. By analysing the interaction between building envelope performance and intermittent conditioning, the study highlights the risks and benefits related to moisture levels, thermal stability, and energy efficiency. The findings provide insights that support better design, operation, and occupant comfort strategies for high-performance Australian housing.
DOI: 10.5281/zenodo.18029814
title: Excel_data_sharing

description: Data set for Journal paper Process optimization on fatigue performance of additive manufactured Ti-6Al-4V in high layer thickness by PBF-LB/M
DOI: 10.5281/zenodo.17250311
title: Code and Dataset for Heart Disease-Related Works

description: This supplementary content includes the collected datasets and code associated with the heart disease-related studies reviewed in a manuscript. Access to these materials is currently unrestricted but will be made publicly available if hopfully the review article is accepted and published. The dataset compilation and code provide reproducible workflows for analysis and facilitate further research in deep learning-based cardiac imaging.
DOI: 10.5281/zenodo.17250312
title: Code and Dataset for Heart Disease-Related Works

description: This supplementary content includes the collected datasets and code associated with the heart disease-related studies reviewed in a manuscript. Access to these materials is currently unrestricted but will be made publicly available if hopfully the review article is accepted and published. The dataset compilation and code provide reproducible workflows for analysis and facilitate further research in deep learning-based cardiac imaging.
DOI: 10.15468/dl.5zytnz
title: Occurrence Download

description: A dataset containing 1648 species occurrences available in GBIF matching the query:
{
 "TaxonKey" : [
 "is Bolitoglossa adspersa"
 ]
}

 The dataset includes 1648 records from 50 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0063672-251120083545085/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.